id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1976-N-0026-0002,FDA,FDA-1976-N-0026,"Letter from Poly Pharmaceuticals, Inc. to FDA/DDM",Other,Letter(s),2011-06-26T04:00:00Z,2011,6,2011-06-26T04:00:00Z,,2014-10-14T17:03:14Z,,0,0,0900006480bdddf0
FDA-1976-N-0026-0001,FDA,FDA-1976-N-0026,"Cold, Cough, Allergy, Bronchodilator and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amerndment of Final Monograph for OTC Antitussive Drug Products; Technical Amendment - Notice of Final Rule",Notice,NFR-Notice of Final Rule,2007-11-30T05:00:00Z,2007,11,,,2014-10-14T17:01:15Z,72,0,0,090000648051b4ed